The new NICE guidelines recommend healthcare professionals offer B12 blood tests to anyone with at least one symptom or sign and one or more risk factors
Among the 12% of adults who have ever taken GLP-1 drugs, most report taking them, at least in part, to treat a chronic condition like diabetes or heart disease, with fewer saying they took them only to lose weight
"That variability in sourcing is one of the biggest concerns, particularly when it comes to purity, dosing consistency and overall quality control." The FDA does not allow production of BPC-157, GHK-Cu, KPV and ipamorelin in the U.S., for example, by compounding pharmacies because of safety concerns , so people are ordering them from overseas usually from China
Harkavyi, A., Abuirmeileh, A., Lever, R., Kingsbury, A
But these claims by thought leaders are despite the fact that BPC-157 has very little safety data and no rigorous human clinical trials an aberration of sorts for something commonly injected into the body by its users
A newer study, published in [29] , showed that 90% of patients using GLP-1RAs had slower gastrointestinal movement when tested with wireless motility capsules